There were no significant differences in the levels of EMPs (CD144+), leukocyte‐derived microparticle (LMPs), or phosphatidylserine expressing microparticle (PS + MPs) between AF patients and healthy controls (Table 3). This evidence concerns the gene CDH5 and atrial fibrillation.